Advances in the prognostication and management of advanced MDS in children

British Journal of Haematology

Volumn 154, Issue 2, 2011, Pages 185-195

  Hasle, Henrik ^a   Niemeyer, Charlotte M ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

AML; Children; HSCT; MDS; RAEB

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMIFOSTINE; ANGIOGENESIS INHIBITOR; ANTILEUKEMIC AGENT; AZACITIDINE; CYTOTOXIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT;

ACQUIRED HEMOLYTIC ANEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DEPRESSION; BONE MARROW EXAMINATION; CANCER SURVIVAL; CHILDHOOD DISEASE; CLINICAL FEATURE; CYTOGENETICS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EVENT FREE SURVIVAL; FAMILIAL DISEASE; GENDER; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; KARYOTYPE; LEUKEMIA RELAPSE; LOW DRUG DOSE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REVIEW; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 79959818298     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08724.x     Document Type: Review

References (106)

1. Abrahamsson, J., Forestier, E., Heldrup, J., Jahnukainen, K., Jonsson, O.G., Lausen, B., Palle, J., Zeller, B. & Hasle, H. (2011) Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. Journal of Clinical Oncology, 29, 10-15.
2. Aktas, D. & Tuncbilek, E. (2006) Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study. Cancer Genetics and Cytogenetics, 171, 72-75.
3. Albitar, M., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H.M., Rogers, A., Jilani, I., Lin, C.W., Pierce, S., Freireich, E.J. & Estey, E.H. (2002) Myelodysplastic syndrome is not merely "preleukemia". Blood, 100, 791-798.
4. Alter, B.P., Giri, N., Savage, S.A., Peters, J.A., Loud, J.T., Leathwood, L., Carr, A.G., Greene, M.H. & Rosenberg, P.S. (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British Journal of Haematology, 150, 179-188.
5. Bader, P., Niemeyer, C., Willasch, A., Kreyenberg, H., Strahm, B., Kremens, B., Gruhn, B., Dilloo, D., Vormoor, J., Lang, P., Niethammer, D., Klingebiel, T. & Beck, J.F. (2005) Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. British Journal of Haematology, 128, 649-658.
6. Bagby, G.C. & Alter, B.P. (2006) Fanconi anemia. Seminars in Hematology, 43, 147-156.
7. Barnard, D.R., Kalousek, D.K., Wiersma, S.R., Lange, B.J., Benjamin, D.R., Arthur, D.C., Buckley, J.D., Kobrinsky, N., Neudorf, S., Sanders, J., Miller, L.P., DeSwarte, J., Shina, D.C., Hammond, G.D. & Woods, W.G. (1996) Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group. Leukemia, 10, 5-12.
8. Barnard, D.R., Lange, B., Alonzo, T.A., Buckley, J., Kobrinsky, J.N., Gold, S., Neudorf, S., Sanders, J., Burden, L. & Woods, W.G. (2002) Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood, 100, 427-434.
9. Baumann, I., Niemeyer, C.M., Bennett, J.M. & Shannon, K. (2008) Childhood myelodysplastic syndrome. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 104-107. IARC, Lyon.
10. Benaim, E., Hvizdala, E.V., Papenhausen, P. & Moscinski, L.C. (1995) Spontaneous remission in monosomy 7 myelodysplastic syndrome. British Journal of Haematology, 89, 947-948.
11. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
12. Busque, L. & Gilliland, D.G. (1998) X-inactivation analysis in the 1990s: promise and potential problems. Leukemia, 12, 128-135.
13. Calado, R.T. & Young, N.S. (2009) Telomere diseases. The New England Journal of Medicine, 361, 2353-2365.
14. Cantù-Rajnoldi, A., Fenu, S., Kerndrup, G., van Wering, E.R., Niemeyer, C.M. & Baumann, I. (2005) Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Annals of Hematology, 84, 429-433.
15. Castro-Malaspina, H., Harris, R.E., Gajewski, J., Ramsay, N., Collins, R., Dharan, B., King, R. & Deeg, H.J. (2002) Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood, 99, 1943-1951.
16. Cesaro, S., Oneto, R., Messina, C., Gibson, B.E., Buzyn, A., Steward, C., Gluckman, E., Breddius, R., Boogaerts, M., Vermylen, C., Veys, P., Marsh, J., Badell, I., Michel, G., Gungor, T., Niethammer, D., Bordigoni, P., Oswald, C., Favre, C., Passweg, J. & Dini, G. (2005) Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. British Journal of Haematology, 131, 231-236.
17. Chan, G.C.F., Wang, W.C., Raimondi, S.C., Behm, F.G., Krance, R.A., Chen, G., Freiberg, A., Ingram, L., Butler, D. & Head, D.R. (1997) Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Leukemia, 11, 206-211.
18. Chang, C., Storer, B.E., Scott, B.L., Bryant, E.M., Shulman, H.M., Flowers, M.E., Sandmaier, B.M., Witherspoon, R.P., Nash, R.A., Sanders, J.E., Bedalov, A., Hansen, J.A., Clurman, B.E., Storb, R., Appelbaum, F.R. & Deeg, H.J. (2007) Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood, 110, 1379-1387.
19. Cioc, A.M., Wagner, J.E., MacMillan, M.L., Defor, T. & Hirsch, B. (2010) Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics. American Journal of Clinical Pathology, 133, 92-100.
20. Creutzig, U., Bender-Götze, C., Ritter, J., Zimmermann, M., Stollmann-Gibbels, B., Körholz, D. & Niemeyer, C. (1998) The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-T. Leukemia, 12, 652-659.
21. De Simone, A., Cantù-Rajnoldi, A., Sainati, L., D'Avanzo, M., Allen, M., Maserati, E., Pasquali, F. & Aricò, M. (2001) Spontaneous remission from RAEB in a child. Leukemia, 15, 856-857.
22. Delhommeau, F., Dupont, S., Della Valle, V., James, C., Trannoy, S., Masse, A., Kosmider, O., Le Couedic, J.P., Robert, F., Alberdi, A., Lecluse, Y., Plo, I., Dreyfus, F.J., Marzac, C., Casadevall, N., Lacombe, C., Romana, S.P., Dessen, P., Soulier, J., Viguie, F., Fontenay, M., Vainchenker, W. & Bernard, O.A. (2009) Mutation in TET2 in myeloid cancers. The New England Journal of Medicine, 360, 2289-2301.
23. Elghetany, M.T. (2007) Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Archives of Pathology & Laboratory Medicine, 131, 1110-1116.
24. Fenaux, P., Mufti, G.J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., Gore, S.D., Seymour, J.F., Bennett, J.M., Byrd, J., Backstrom, J., Zimmerman, L., McKenzie, D., Beach, C. & Silverman, L.R. (2009) Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncology, 10, 223-232.
25. Field, J.J., Mason, P.J., An, P., Kasai, Y., McLellan, M., Jaeger, S., Barnes, Y.J., King, A.A., Bessler, M. & Wilson, D.B. (2006) Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. Journal of Pediatric Hematology/Oncology, 28, 450-453.
26. Führer, M., Rampf, U., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A. & Bender-Goetze, C. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood, 106, 2102-2104.
27. Ganly, P., Walker, L.C. & Morris, C.M. (2004) Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leukemia and Lymphoma, 45, 1-10.
28. Goel, R., Kumar, R. & Bakhshi, S. (2007) Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 29, 725-727.
29. Göhring, G., Michalova, K., Beverloo, H.B., Betts, D., Harbott, J., Haas, O.A., Kerndrup, G., Sainati, L., Bergstraesser, E., Hasle, H., Stary, J., Trebo, M., van den Heuvel-Eibrink, M.M., Zecca, M., van Wering, E.R., Fischer, A., Noellke, P., Strahm, B., Locatelli, F., Niemeyer, C.M. & Schlegelberger, B. (2010) Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood, 116, 3766-3799.
30. Greenberg, P., Cox, C., Le Beau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
31. Harrison, C.J., Hills, R.K., Moorman, A.V., Grimwade, D.J., Hann, I., Webb, D.K., Wheatley, K., de Graaf, S.S., van den Berg, E., Burnett, A.K. & Gibson, B.E. (2010) Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. Journal of Clinical Oncology, 28, 2674-2681.
32. Hasegawa, D., Manabe, A., Kubota, T., Kawasaki, H., Hirose, I., Ohtsuka, Y., Tsuruta, T., Ebihara, Y., Goto, Y., Zhao, X.Y., Sakashita, K., Koike, K., Isomura, M., Kojima, S., Hoshika, A., Tsuji, K. & Nakahata, T. (2005) Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia. British Journal of Haematology, 128, 805-812.
33. Hasle, H. (1997) Turner syndrome and myelodysplastic syndrome. No reason to alert. Journal of Pediatric Hematology/Oncology, 19, 179.
34. Hasle, H., Kerndrup, G. & Jacobsen, B.B. (1995a) Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia, 9, 1569-1572.
35. Hasle, H., Clausen, N., Pedersen, B. & Bendix-Hansen, K. (1995b) Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype. Cancer Genetics and Cytogenetics, 79, 79-81.
36. Hasle, H., Kerndrup, G., Yssing, M., Clausen, N., Østergaard, E., Jacobsen, N. & Jacobsen, B.B. (1996) Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia, 10, 1269-1273.
37. Hasle, H., Aricò, M., Basso, G., Biondi, A., Cantù-Rajnoldi, A., Creutzig, U., Fenu, S., Fonatsch, C., Haas, O.A., Harbott, J., Kardos, G., Kerndrup, G., Mann, G., Niemeyer, C.M., Ptoszkova, H., Ritter, J., Slater, R., Stary, J., Stollmann-Gibbels, B., Testi, A.M., van Wering, E.R. & Zimmermann, M. (1999a) Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia, 13, 376-385.
38. Hasle, H., Wadsworth, L.D., Massing, B.G., McBride, M. & Schultz, K.R. (1999b) A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. British Journal of Haematology, 106, 1027-1032.
39. Hasle, H., Niemeyer, C.M., Chessells, J.M., Baumann, I., Bennett, J.M., Kerndrup, G. & Head, D.R. (2003) A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia, 17, 277-282.
40. Hasle, H., Baumann, I., Bergsträsser, E., Fenu, S., Fischer, A., Kardos, G., Kerndrup, G., Locatelli, F., Rogge, T., Schultz, K.R., Stary, J., Trebo, M., van den Heuvel-Eibrink, M.M., Harbott, J., Nöllke, P. & Niemeyer, C.M. (2004) The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia, 18, 2008-2014.
41. Hasle, H., Alonzo, T.A., Auvrignon, A., Behar, C., Chang, M., Creutzig, U., Fischer, A., Forestier, E., Fynn, A., Haas, O.A., Harbott, J., Harrison, C.J., Heerema, N.A., van den Heuvel-Eibrink, M.M., Kaspers, G.J., Locatelli, F., Noellke, P., Polychronopoulou, S., Ravindranath, Y., Razzouk, B., Reinhardt, D., Savva, N.N., Stark, B., Suciu, S., Tsukimoto, I., Webb, D.K., Wojcik, D., Woods, W.G., Zimmermann, M., Niemeyer, C.M. & Raimondi, S.C. (2007) Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood, 109, 4641-4647.
42. Head, D.R. (1996) Revised classification of acute myeloid leukemia. Leukemia, 10, 1826-1831.
43. Head, D.R. (2002) Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Current Opinion in Oncology, 14, 19-23.
44. Hicsönmez, G., Cetin, M., Yenicesu, I., Olcay, L., Koc, A., Aktas, D., Tuncbilek, E. & Tuncer, M. (2001) Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom. Leukemia and Lymphoma, 42, 665-674.
45. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
46. Jekic, B., Novakovic, I., Lukovic, L., Kuzmanovic, M., Popovic, B., Pastar, I., Milasin, J., Bunjevacki, G. & Bunjevacki, V. (2004) Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes. Cancer Genetics and Cytogenetics, 154, 180-182.
47. Jekic, B., Novakovic, I., Lukovic, L., Kuzmanovic, M., Popovic, B., Milasin, J., Bunjevacki, G., Damnjanovic, T., Cvjeticanin, S. & Bunjevacki, V. (2006) Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 166, 163-165.
48. Kalwak, K., Wojcik, D., Gorczynska, E., Toporski, J., Turkiewicz, D., Slociak, M., Ussowicz, M., Pajdosz, K., Socha, P. & Chybicka, A. (2004) Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative? Transplantation Proceedings, 36, 1574-1577.
49. Kardos, G., Baumann, I., Passmore, S.J., Locatelli, F., Hasle, H., Schultz, K.R., Stary, J., Schmitt-Gräff, A., Fischer, A., Harbott, J., Chessells, J.M., Hann, I., Fenu, S., Cantù-Rajnoldi, A., Kerndrup, G., van Wering, E.R., Rogge, T., Nöllke, P. & Niemeyer, C.M. (2003) Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood, 102, 1997-2003.
50. Karow, A., Flotho, C., Schneider, M., Fliegauf, M. & Niemeyer, C.M. (2010) Mutations of the Shwachman-Bodian-Diamond syndrome (SBDS) gene in patients presenting with refractory cytopenia - do we have to screen? Haematologica, 95, 689-690.
51. Kojima, S., Ohara, A., Tsuchida, M., Kudoh, T., Hanada, R., Okimoto, Y., Kaneko, T., Takano, T., Ikuta, K. & Tsukimoto, I. (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood, 100, 786-790.
52. Leahey, A., Friedman, D.L. & Bunin, N.J. (1999) Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia. Bone Marrow Transplantation, 23, 21-25.
53. Loeb, L.A. (2001) A mutator phenotype in cancer. Cancer Research, 61, 3230-3239.
54. Lopes, L.F. & Lorand Metze, I. (1999) Childhood myelodysplastic syndromes in a Brazilian population. Pediatric Hematology and Oncology, 16, 347-353.
55. Luna-Fineman, S., Shannon, K.M. & Lange, B.J. (1995) Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood, 85, 1985-1999.
56. Luna-Fineman, S., Shannon, K.M., Atwater, S.K., Davis, J., Masterson, M., Ortega, J., Sanders, J., Steinherz, P., Weinberg, V. & Lange, B.J. (1999) Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood, 93, 459-466.
57. Madureira, A.B., Eapen, M., Locatelli, F., Teira, P., Zhang, M.J., Davies, S.M., Picardi, A., Woolfrey, A., Chan, K.W., Socie, G., Vora, A., Bertrand, Y., Sales-Bonfim, C.M., Gluckman, E., Niemeyer, C. & Rocha, V. (2011) Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia, 25, 449-454.
58. Mantadakis, E., Shannon, K.M., Singer, D.A., Finkelstein, J., Chan, K.W., Hilden, J.M. & Sandler, E.S. (1999) Transient monosomy 7. A case series in children and review of the literature. Cancer, 85, 2655-2661.
59. Maserati, E., Aprili, F., Vinante, F., Locatelli, F., Amendola, G., Zatterale, A., Milone, G., Minelli, A., Bernardi, F., Lo, C.F. & Pasquali, F. (2002) Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases. Genes Chromosomes and Cancer, 33, 93-97.
60. Maserati, E., Minelli, A., Pressato, B., Valli, R., Crescenzi, B., Stefanelli, M., Menna, G., Sainati, L., Poli, F., Panarello, C., Zecca, M., Curto, F.L., Mecucci, C., Danesino, C. & Pasquali, F. (2006) Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies. Genes, Chromosomes & Cancer, 45, 375-382.
61. Maserati, E., Panarello, C., Morerio, C., Valli, R., Pressato, B., Patitucci, F., Tassano, E., Di Cesare-Merlone, A., Cugno, C., Balduini, C.L., Lo, C.F., Dufour, C., Locatelli, F. & Pasquali, F. (2008) Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica, 93, 1271-1273.
62. Maserati, E., Pressato, B., Valli, R., Minelli, A., Sainati, L., Patitucci, F., Marletta, C., Mastronuzzi, A., Poli, F., Lo, C.F., Locatelli, F., Danesino, C. & Pasquali, F. (2009) The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies. British Journal of Haematology, 145, 190-197.
63. Minelli, A., Maserati, E., Nicolis, E., Zecca, M., Sainati, L., Longoni, D., Lo, C.F., Menna, G., Poli, F., De, P.E., Cipolli, M., Locatelli, F., Pasquali, F. & Danesino, C. (2009) The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome. Leukemia, 23, 708-711.
64. Nagatoshi, Y., Okamura, J., Ikuno, Y., Akamatsu, M. & Tasaka, H. (1997) Therapeutic trial of intensified conditioning regimen with high- dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children. International Journal of Hematology, 65, 269-275.
65. Nilsson, L., Astrand-Grundström, I., Anderson, K., Arvidsson, I., Hokland, P., Bryder, D., Kjeldsen, L., Johansson, B., Hellström-Lindberg, E., Hast, R. & Jacobsen, S.E. (2002) Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood, 100, 259-267.
66. Ohara, A., Kojima, S., Hamajima, N., Tsuchida, M., Imashuku, S., Ohta, S., Sasaki, H., Okamura, J., Sugita, K., Kigasawa, H., Kiriyama, Y., Akatsuka, J. & Tsukimoto, I. (1997) Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood, 90, 1009-1013.
67. Ortmann, C.A., Niemeyer, C.M., Wawer, A., Ebell, W., Baumann, I. & Kratz, C.P. (2006) TERC mutations in children with refractory cytopenia. Haematologica, 91, 707-708.
68. Owen, C., Barnett, M. & Fitzgibbon, J. (2008) Familial myelodysplasia and acute myeloid leukaemia - a review. British Journal of Haematology, 140, 123-132.
69. Pabst, T., Eyholzer, M., Haefliger, S., Schardt, J. & Mueller, B.U. (2008) Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. Journal of Clinical Oncology, 26, 5088-5093.
70. Parker, T.M., Klaassen, R.J. & Johnston, D.L. (2008) Spontaneous remission of myelodysplastic syndrome with monosomy 7 in a young boy. Cancer Genetics and Cytogenetics, 182, 122-125.
71. Passmore, S.J., Hann, I.M., Stiller, C.A., Ramani, P., Swansbury, G.J., Gibbons, B., Reeves, B.R. & Chessells, J.M. (1995) Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood, 85, 1742-1750.
72. Passmore, S.J., Chessells, J.M., Kempski, H., Hann, I.M., Brownbill, P.A. & Stiller, C.A. (2003) Paediatric MDS and JMML in the UK: a population based study of incidence and survival. British Journal of Haematology, 121, 758-767.
73. Pedersen-Bjergaard, J., Christiansen, D.H., Desta, F. & Andersen, M.K. (2006) Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia, 20, 1943-1949.
74. la Porta, M.G., Malcovati, L., Boveri, E., Travaglino, E., Pietra, D., Pascutto, C., Passamonti, F., Invernizzi, R., Castello, A., Magrini, U., Lazzarino, M. & Cazzola, M. (2009) Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. Journal of Clinical Oncology, 27, 754-762.
75. Roela, R.A., Carraro, D.M., Brentani, H.P., Kaiano, J.H., Simao, D.F., Guarnieiro, R., Lopes, L.F., Borojevic, R. & Brentani, M.M. (2007) Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes. Leukemia Research, 31, 579-589.
76. Rosati, S., Anastasi, J. & Vardiman, J. (1996) Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Seminars in Hematology, 33, 111-126.
77. Rosenberg, P.S., Huang, Y. & Alter, B.P. (2004) Individualized risks of first adverse events in patients with Fanconi anemia. Blood, 104, 350-355.
78. Rosenberg, P.S., Zeidler, C., Bolyard, A.A., Alter, B.P., Bonilla, M.A., Boxer, L.A., Dror, Y., Kinsey, S., Link, D.C., Newburger, P.E., Shimamura, A., Welte, K. & Dale, D.C. (2010) Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. British Journal of Haematology, 150, 196-199.
79. Sasaki, H., Manabe, A., Kojima, S., Tsuchida, M., Hayashi, Y., Ikuta, K., Okamura, I., Koike, K., Ohara, A., Ishii, E., Komada, Y., Hibi, S. & Nakahata, T. (2001) Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia, 15, 1713-1720.
80. Scheurlen, W., Borkhardt, A., Ritterbach, J. & Huppertz, H.I. (1994) Spontaneous hematological remission in a boy with myelodysplastic syndrome and monosomy 7. Leukemia, 8, 1435-1438.
81. Sheng, X.M., Kawamura, M., Ohnishi, H., Ida, K., Hanada, R., Kojima, S., Kobayashi, M., Bessho, F., Yanagisawa, M. & Hayashi, Y. (1997) Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia. Leukemia Research, 21, 697-701.
82. Shinawi, M., Erez, A., Shardy, D.L., Lee, B., Naeem, R., Weissenberger, G., Chinault, A.C., Cheung, S.W. & Plon, S.E. (2008) Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q. Blood, 112, 1042-1047.
83. Skinner, R., Velangi, M. & Bown, N. (2008) Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7. Pediatric Blood & Cancer, 50, 670-672.
84. Smith, O.P. (2002) Shwachman-Diamond syndrome. Seminars in Hematology, 39, 95-102.
85. Stary, J., Baumann, I., Creutzig, U., Harbott, J., Michalova, K. & Niemeyer, C. (2008) Getting the numbers straight in pediatric MDS: distribution of subtypes after exclusion of down syndrome. Pediatric Blood & Cancer, 50, 435-436.
86. Strahm, B., Nollke, P., Zecca, M., Korthof, E.T., Bierings, M., Furlan, I., Sedlacek, P., Chybicka, A., Schmugge, M., Bordon, V., Peters, C., O'Marcaigh, A., de Heredia, C.D., Bergstraesser, E., Moerloose, B.D., van den Heuvel-Eibrink, M.M., Stary, J., Trebo, M., Wojcik, D., Niemeyer, C.M. & Locatelli, F. (2011) Hematopoietic stem cell transplantation for advanced MDS in children: results of the EWOG-MDS98 study. Leukemia, 25, 455-462.
87. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon.
88. Tamaki, H., Ogawa, H., Ohyashiki, K., Ohyashiki, J.H., Iwama, H., Inoue, K., Soma, T., Oka, Y., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E.H., Kawakami, M., Fuchigami, K., Tomonaga, M., Toyama, K., Aozasa, K., Kishimoto, T. & Sugiyama, H. (1999) The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia, 13, 393-399.
89. Tamura, K., Kanazawa, T., Suzuki, M., Koitabashi, M., Ogawa, C. & Morikawa, A. (2006) Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome. American Journal of Hematology, 81, 139-141.
90. Tefferi, A., Thibodeau, S.N. & Solberg, L.A. (1990) Clonal studies in themyelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood, 75, 1770-1773.
91. Tehranchi, R., Woll, P.S., Anderson, K., Buza-Vidas, N., Mizukami, T., Mead, A.J., Astrand-Grundström, I., Strömbeck, B., Horvat, A., Ferry, H., Dhanda, R.S., Hast, R., Rydén, T., Vyas, P., Göhring, G., Schlegelberger, B., Johansson, B., Hellström-Lindberg, E., List, A., Nilsson, L. & Jacobsen, S.E. (2010) Persistent malignant stem cells in del(5q) myelodysplasia in remission. New England Journal of Medicine, 363, 1025-1037.
92. Tsurusawa, M., Manabe, A., Hayashi, Y., Akiyama, Y., Kigasawa, H., Inada, H., Noguchi, Y., Sawai, N., Kobayashi, R., Nagatoshi, Y., Kawakami, K., Kojima, S. & Nakahata, T. (2005) Therapy-related myelodysplastic syndrome in childhood: a retrospective study of 36 patients in Japan. Leukemia Research, 29, 625-632.
93. Valent, P., Horny, H.P., Bennett, J.M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.J., Krieger, O., Loken, M., van de, L.A., Ogata, K., Orfao, A., Pfeilstocker, M., Ruter, B., Sperr, W.R., Stauder, R. & Wells, D.A. (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leukemia Research, 31, 727-736.
94. Vardiman, J.W., Harris, N.L. & Brunning, R.D. (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100, 2292-2302.
95. Veltroni, M., Sainati, L., Zecca, M., Fenu, S., Tridello, G., Testi, A.M., Merlone, A.D., Buldini, B., Leszl, A., Lo, N.L., Longoni, D., Bernini, G. & Basso, G. (2009) Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? Pediatric Blood & Cancer, 52, 357-363.
96. Vidal, D.O., Paixao, V.A., Brait, M., Souto, E.X., Caballero, O.L., Lopes, L.F. & Vettore, A.L. (2007) Aberrant methylation in pediatric myelodysplastic syndrome. Leukemia Research, 31, 175-181.
97. Vlachos, A., Ball, S., Dahl, N., Alter, B.P., Sheth, S., Ramenghi, U., Meerpohl, J., Karlsson, S., Liu, J.M., Leblanc, T., Paley, C., Kang, E.M., Leder, E.J., Atsidaftos, E., Shimamura, A., Bessler, M., Glader, B. & Lipton, J.M. (2008) Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology, 142, 859-876.
98. Webb, D.K.H., Passmore, S.J., Hann, I.M., Harrison, G., Wheatley, K. & Chessells, J.M. (2002) Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. British Journal of Haematology, 117, 33-39.
99. Wells, R.J., Arthur, D.C., Srivastava, A., Heerema, N.A., Le Beau, M., Alonzo, T.A., Buxton, A.B., Woods, W.G., Howells, W.B., Benjamin, D.R., Betcher, D.L., Buckley, J.D., Feig, S.A., Kim, T., Odom, L.F., Ruymann, F.B., Smithson, W.A., Tannous, R., Whitt, J.K., Wolff, L., Tjoa, T. & Lampkin, B.C. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia, 16, 601-607.
100. de Witte, T., Hermans, J., Vossen, J., Bacigalupo, A., Meloni, G., Jacobsen, N., Ruutu, T., Ljungman, P., Gratwohl, A., Runde, V., Niederwieser, D., Van Biezen, A., Devergie, A., Cornelissen, J., Jouet, J.P., Arnold, R. & Apperley, J. (2000) Haematopoietic stem cell transplantation for patients with myelo- dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology, 110, 620-630.
101. de Witte, T., Suciu, S., Verhoef, G., Labar, B., Archimbaud, E., Aul, C., Selleslag, D., Ferrant, A., Wijermans, P., Mandelli, F., Amadori, S., Jehn, U., Muus, P., Boogaerts, M., Zittoun, R., Gratwohl, A., Zwierzina, H., Hagemeijer, A. & Willemze, R. (2001) Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood, 98, 2326-2331.
102. Woodard, P., Barfield, R., Hale, G., Horwitz, E., Leung, W., Ribeiro, R., Rubnitz, J., Srivistava, D.K., Tong, X., Yusuf, U., Raimondi, S., Pui, C.H., Handgretinger, R. & Cunningham, J.M. (2006) Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. Pediatric Blood & Cancer, 47, 931-935.
103. Woods, W.G., Neudorf, S., Gold, S., Sanders, J., Buckley, J.D., Barnard, D.R., Dusenbery, K., DeSwarte, J., Arthur, D.C., Lange, B.J. & Kobrinsky, N.L. (2001) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood, 97, 56-62.
104. Woods, W.G., Barnard, D.R., Alonzo, T.A., Buckley, J.D., Kobrinsky, N., Arthur, D.C., Sanders, J., Neudorf, S., Gold, S. & Lange, B.J. (2002) Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. Journal of Clinical Oncology, 20, 434-440.
105. Yakoub-Agha, I., de La Salmoniere, P., Ribaud, P., Sutton, L., Wattel, E., Kuentz, M., Jouet, J.P., Marit, G., Milpied, N., Deconinck, E., Gratecos, N., Leporrier, M., Chabbert, I., Caillot, D., Damaj, G., Dauriac, C., Dreyfus, F., Francois, S., Molina, L., Tanguy, M.L., Chevret, S. & Gluckman, E. (2000) Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. Journal of Clinical Oncology, 18, 963-971.
106. Zeidler, C., Welte, K., Barak, Y., Barriga, F., Bolyard, A.A., Boxer, L., Cornu, G., Cowan, M.J., Dale, D.C., Flood, T., Freedman, M., Gadner, H., Mandel, H., O'Reilly, R.J., Ramenghi, U., Reiter, A., Skinner, R., Vermylen, C. & Levine, J.E. (2000) Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood, 95, 1195-1198.